Priyanka Shah
Contatto Relazioni con gli Investitori presso KINNATE BIOPHARMA INC.
Posizioni attive di Priyanka Shah
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KINNATE BIOPHARMA INC. | Contatto Relazioni con gli Investitori | - | - |
Storia della carriera di Priyanka Shah
Precedenti posizioni note di Priyanka Shah
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MIRATI THERAPEUTICS | Public Communications Contact | - | 01/04/2022 |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Public Communications Contact | 1 |
| Investor Relations Contact | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Priyanka Shah
- Esperienza
